Plasma and tissue protein substrates

Plasma and tissue protein substrates represent the collective molecular targets of the proteolytic enzyme serratiopeptidase, a metalloprotease originally isolated from the non-pathogenic enterobacterium Serratia marcescens (Bhagat et al., 2013, PMID: 23381144). These substrates primarily include inflammatory mediators such as bradykinin and histamine, as well as structural proteins like fibrin that accumulate at sites of injury or chronic inflammation (Tiwari, 2017, PMID: 29113066). By catalyzing the hydrolysis of these proteins, serratiopeptidase effectively reduces the viscosity of exudates, promotes the drainage of edema, and inhibits the release of pain-inducing amines (Jadhav et al., 2020, PMID: 32680520). This broad proteolytic activity allows the enzyme to function as an anti-inflammatory, anti-edemic, and mucolytic agent in various clinical settings. In the systemic circulation, serratiopeptidase binds to alpha-2-macroglobulin, which masks its antigenicity while preserving its enzymatic capacity to reach inflamed tissues (DrugBank, DB14751). Its role in disease management focuses on conditions characterized by abnormal protein accumulation or excessive inflammatory responses, such as post-traumatic swelling, fibrocystic breast disease, and chronic obstructive pulmonary disease. While it is widely used as a supplement and therapeutic aid, its efficacy is dependent on the specific degradation of these plasma and tissue substrates to restore normal physiological function. The interaction between the enzyme and these substrates is a key mechanism for its therapeutic benefits in reducing pain and promoting tissue repair.

Other names

FibrinBradykininHistamineInflammatory mediatorsSerrapeptase substratesExtracellular proteins

Serratiopeptidase is a proteolytic enzyme that binds to alpha-2-macroglobulin in the blood to reach the site of inflammation. It then catalyzes the hydrolysis of various plasma and tissue proteins, specifically targeting inflammatory mediators like bradykinin and histamine, as well as fibrin deposits (Bhagat et al., 2013, PMID: 23381144). By degrading these substrates, it reduces capillary permeability, dissolves abnormal protein accumulations, and alleviates pain and swelling (Tiwari, 2017, PMID: 29113066).